
Short-term savings, long-term costs: what cuts to medicines optimisation teams could mean for the NHS
Integrated care boards have confirmed to The Pharmaceutical Journal that they are reducing headcount in their medicines optimisation teams, which are primarily formed of pharmacists. What will this mean for the future NHS?…
































